Procaps Group S.A. (NASDAQ:PROC – Get Free Report)’s stock price was down 5.9% during mid-day trading on Friday . The stock traded as low as $1.92 and last traded at $1.92. Approximately 861 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 12,104 shares. The stock had previously closed at $2.04.
Procaps Group Stock Performance
The firm’s 50-day simple moving average is $1.99 and its 200 day simple moving average is $2.39. The company has a market capitalization of $216.61 million, a PE ratio of 3.69 and a beta of 0.16.
About Procaps Group
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Featured Articles
- Five stocks we like better than Procaps Group
- How to Use the MarketBeat Dividend Calculator
- Is Spotify Stock Poised to Soar? Options Traders Think So
- Roth IRA Calculator: Calculate Your Potential Returns
- Misses and Beats: 3 Stocks That Are Moving Markets Right Now
- Stock Market Sectors: What Are They and How Many Are There?
- Cisco on the Rise: AI Potential and Analyst Upgrades Drive Gains
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
